Nantahala Capital Management, LLC Angion Biomedica Corp. Transaction History

Nantahala Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.48 - $1.02 $24,192 - $51,410	-50,402 Reduced 4.88%	982,743 $569,000
Q4 2022 Feb 14, 2023	SELL	$0.8 - $1.0 $26,293 - $32,867	-32,867 Reduced 3.08%	1,033,145 $836,000
Q3 2022 Nov 10, 2022	SELL	$0.94 - $1.23 $61,089 - $79,936	-64,989 Reduced 5.75%	1,066,012 $981,000
Q2 2022 Aug 15, 2022	SELL	$1.1 - $2.23 $46,377 - $94,019	-42,161 Reduced 3.59%	1,131,001 $1.29 Million
Q1 2022 May 13, 2022	SELL	$1.72 - $2.96 $161,451 - $277,846	-93,867 Reduced 7.41%	1,173,162 $2.49 Million
Q4 2021 Feb 14, 2022	BUY	$2.35 - $9.95 $2.7 Million - $11.4 Million	1,148,508 Added 969.03%	1,267,029 $3.67 Million
Q3 2021 Nov 15, 2021	SELL	$9.31 - $13.25 $60,319 - $85,846	-6,479 Reduced 5.18%	118,521 $1.16 Million
Q1 2021 May 14, 2021	BUY	$15.01 - $25.74 $1.88 Million - $3.22 Million	125,000 New	125,000 $2.26 Million

Ticker ANGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,113,300
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nantahala Capital Management, LLC with notifications on news.